Arsenic sulfide reverses cisplatin resistance in non‐small cell lung cancer in vitro and in vivo through targeting PD‐L1

BACKGROUND: Recent studies have found that programmed death ligand 1 (PD‐L1) might be involved in chemotherapy resistance in non‐small cell lung cancer (NSCLC). Arsenic sulfide (As(4)S(4)) has been recognized to have antitumor activities and enhance the cytotoxic effect of chemotherapy drugs. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Wei, Sun, Yinping, Cheng, Yuping, Ma, Xiao, Du, Weina, Shi, Wenna, Guo, Qisen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487818/
https://www.ncbi.nlm.nih.gov/pubmed/34469060
http://dx.doi.org/10.1111/1759-7714.14136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487818/
https://www.ncbi.nlm.nih.gov/pubmed/34469060
http://dx.doi.org/10.1111/1759-7714.14136

Ejemplares similares